← FDA DRUG APPROVALS

FDA NDA · NDA022439

ZUTRIPRO

Sponsor: PERSION

APPLICATION
NDA022439
TYPE
NDA
ORIGINAL APPROVAL
2011-06-08
LATEST ACTION
2018-06-28
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

ZUTRIPRO · ReferenceDiscontinued
CHLORPHENIRAMINE MALEATE 4MG/5ML, HYDROCODONE BITARTRATE 5MG/5ML, PSEUDOEPHEDRINE HYDROCHLORIDE 60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SOLUTION · ORAL

Approval history

2018-06-28Labeling · Supplement 10 · standard — Label ↗AP
2017-01-13Labeling · Supplement 9 · standard — Label ↗AP
2014-09-26Manufacturing (CMC) · Supplement 7 · standardAP
2011-06-08Type 4 - New Combination · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →